Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Agios Pharmaceuticals (AGIO) Return on Equity (2016 - 2025)

Agios Pharmaceuticals (AGIO) has disclosed Return on Equity for 12 consecutive years, with 0.33% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Equity fell 76.0% year-over-year to 0.33%, compared with a TTM value of 0.33% through Dec 2025, down 76.0%, and an annual FY2025 reading of 0.3%, down 87.0% over the prior year.
  • Return on Equity was 0.33% for Q4 2025 at Agios Pharmaceuticals, down from 0.3% in the prior quarter.
  • Across five years, Return on Equity topped out at 1.46% in Q4 2021 and bottomed at 0.53% in Q2 2024.
  • Average Return on Equity over 5 years is 0.23%, with a median of 0.0% recorded in 2022.
  • The sharpest move saw Return on Equity skyrocketed 186bps in 2021, then crashed -143bps in 2022.
  • Year by year, Return on Equity stood at 1.46% in 2021, then tumbled by -100bps to 0.0% in 2022, then plummeted by -11652bps to 0.42% in 2023, then skyrocketed by 200bps to 0.42% in 2024, then plummeted by -179bps to 0.33% in 2025.
  • Business Quant data shows Return on Equity for AGIO at 0.33% in Q4 2025, 0.3% in Q3 2025, and 0.46% in Q2 2025.